α52 isn't mobile-compatible yet. It's recommended to use a desktop or laptop.
α52
Alpha 52
Where AI meets Quant
GILD
148.95
+ 3.60%
Gilead Sciences, Inc.
Pharma & Biotech

News Sentiment

59m ago
Bullish 65%
Bearish 35%

News Summary

The company's stock has shown mixed recent performance, gaining 3.6% over the past day and 6.6% over the past month, but declining 1.6% over the past week. Over a three-month period, it has significantly outperformed its sector peers with an 18.4% gain. Analysts remain highly optimistic about the stock's future prospects despite the lack of a single headline event driving the current price action. The focus is on recent share price momentum and fundamental valuation signals.
Home Stock Model Insights
Support expand_more